Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Nanorobotics logo — Leading developer of programmable, light-activated, nanorobo...

Nanorobotics

Leading developer of programmable, light-activated, nanorobots in medicine, targeting, destroying and curing cells

Founded 2019 Israel Israel 3 employees Biotechnology, Pharmaceutical

General Information

Company Name Nanorobotics
Founded Year 2019
Location Israel Israel +1
Employees 3
Industries Biotechnology, Pharmaceutical
Social

Get notified when Nanorobotics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Nanorobotics

Nanorobotics is a biotechnology and pharmaceutical startup based in Israel, founded in 2019. The company is gaining attention as a leading developer of programmable, light-activated nanorobots in medicine. With the slogan "Leading developer of programmable, light-activated, nanorobots in medicine, targeting, destroying and curing cells," Nanorobotics has developed proprietary technology using Molecular NanoMachines to promptly target and kill cancer cells. These tiny machines, measuring 1 nm in size, can mechanically kill cells by drilling and tunneling through the membrane until disrupting the nucleus. Nanorobotics is pioneering a new modality in oncology called Mechanotherapy. Recent animal studies have demonstrated a dramatic reduction in melanoma growth, particularly in cases highly resistant to immunotherapy. The company's Mechanotherapy treatment is notably decoupled from any cancer pathogenesis, mutational rate, or tumor microenvironment, highlighting its potential as a versatile and effective approach to cancer treatment. The development of programmable, light-activated nanorobots by Nanorobotics offers a revolutionary new area in nanomedicine, with significant potential for impacting the field of medicine. As of now, there is no information available on the last investment or the investors involved. Nanorobotics' approach to cancer treatment and technology presents a promising opportunity for investment in the biotechnology and pharmaceutical industries. Further monitoring and analysis of their progress in clinical trials and commercialization efforts are warranted for potential investors seeking opportunities in cutting-edge medical technologies.

Find out more at nanorobotics.tech.

Taxonomy: nanotechnology, nanomedicine, cancer treatment, oncology, nanorobotics, molecular nanomachines, mechanotherapy, programmable technology, light-activated, nanorobots, cancer research, cell targeting, animal studies, innovative medical technology

No funding data available for Nanorobotics yet.

Get notified when Nanorobotics raises funding

Nanorobotics Alternatives & Competitors

Nanorobotics vs
Immunowake, Inc.
Immunowake, Inc. United States

Immunowake Inc. is a private, pre-clinical stage biotechnology company focused on cancer drug discov...

Series A
2 employees
Biotechnology
Nanorobotics vs
Halda Therapeutics
Halda Therapeutics United States

Taking Hold, Conquering Cancer. Discovering novel medicines to target cancer and overcome drug resi...

40 employees
Nanorobotics vs
Halda Therapeutics
Halda Therapeutics United States

Taking Hold, Conquering Cancer. Discovering novel medicines to target cancer and overcome drug resi...

Acquired
39 employees
Biotechnology

FAQ About Nanorobotics

Leading developer of programmable, light-activated, nanorobots in medicine, targeting, destroying and curing cells
Nanorobotics was founded in 2019.
Nanorobotics is headquartered in Israel.
Nanorobotics operates in the following industries: Biotechnology, Pharmaceutical.
Nanorobotics has approximately 3 employees.
Top alternatives and competitors to Nanorobotics include Immunowake, Inc., Halda Therapeutics, Halda Therapeutics, Oncorus, Duet BioTherapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nanorobotics and Immunowake, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Nanorobotics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes